Recent Updates
Recently added Catalysts
KURA Positive Sentiment Score: 70/100

Kura Oncology to Participate in Three Upcoming Investor Conferences

Tuesday, February 25, 2025 1 min read
Key Takeaway: Kura Oncology has announced its participation in three investor conferences scheduled for March 2025. CEO Troy Wilson will engage in fireside chats at the TD Cowen Health Care Conference, Barclays Global Healthcare Conference, and Leerink Partners Global Biopharma Conference. The company aims to share its vision and progress in precision medicine for cancer treatment, which reflects its commitment to innovation in the biopharmaceutical field.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kura Oncology is actively engaging with investors through three major conferences.
  • Participation in high-profile conferences indicates growth and interest in the company.
  • The company's commitment to precision medicines for cancer treatment showcases its innovative approach.

Full Press Release Details

SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in three upcoming investor conferences:
A fireside chat at the TD Cowen Health Care Conference in Boston at 2:30 p.m. ET / 11:30 a.m. PT on March 4, 2025;
A fireside chat at the Barclays Global Healthcare Conference in Miami at 9:30 a.m. ET / 6:30 a.m. PT on March 11, 2025; and
A fireside chat at the Leerink Partners Global Biopharma Conference in Miami at 8:00 a.m. ET / 5:00 a.m. PT on March 12, 2025.
Live audio webcasts will be available in the Investors section of Kura’s website at https://kuraoncology.com/, with archived replays available following all three events.
patti.bank@icrhealthcare.com
Alexandra Weingarten
Associate Director, Corporate Communications
& Investor Relations
alexandra@kuraoncology.com

Frequently Asked Questions

What company is hosting investor conferences in March 2025?

Kura Oncology, Inc. is hosting investor conferences in March 2025.

Who is presenting at the investor conferences?

Troy Wilson, Ph.D., J.D., the CEO of Kura Oncology, will present.

When is the TD Cowen Health Care Conference?

The TD Cowen Health Care Conference is on March 4, 2025.

Where can I find the live webcasts of the events?

Live webcasts will be available on Kura's Investors section of their website.

What is the date for the Barclays Global Healthcare Conference?

The Barclays Global Healthcare Conference is on March 11, 2025.

Tags: KURA Viatris Investor Conferences Healthcare Kura Oncology precision medicine cancer treatment investor conferences Troy Wilson
Last updated: Feb 25, 2025